Synthesis of 2-chloropurine ribosides with chiral amino acid amides at C6 and their evaluation as A 1 adenosine receptor agonists

A series of purine ribonucleosides bearing chiral amino acid amides at the C6 position of 2-chloropurine was synthesized. Molecular docking of the synthesized analogs of 2-chloroadenosine by their affinity for A adenosine receptors (A ARs) was conducted. The investigation of A AR stimulating activit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic chemistry 2022-05, Vol.126, p.105878
Hauptverfasser: Berzina, Maria Ya, Eletskaya, Barbara Z, Kayushin, Alexei L, Dorofeeva, Elena V, Lutonina, Olga I, Fateev, Ilya V, Paramonov, Alexander S, Kostromina, Maria A, Zayats, Evgeniy A, Abramchik, Yulia A, Maltsev, Dmitriy V, Naumenko, Ludmila V, Taran, Alena S, Yakovlev, Dmitry S, Spasov, Alexander A, Miroshnikov, Anatoly I, Esipov, Roman S, Konstantinova, Irina D
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 105878
container_title Bioorganic chemistry
container_volume 126
creator Berzina, Maria Ya
Eletskaya, Barbara Z
Kayushin, Alexei L
Dorofeeva, Elena V
Lutonina, Olga I
Fateev, Ilya V
Paramonov, Alexander S
Kostromina, Maria A
Zayats, Evgeniy A
Abramchik, Yulia A
Maltsev, Dmitriy V
Naumenko, Ludmila V
Taran, Alena S
Yakovlev, Dmitry S
Spasov, Alexander A
Miroshnikov, Anatoly I
Esipov, Roman S
Konstantinova, Irina D
description A series of purine ribonucleosides bearing chiral amino acid amides at the C6 position of 2-chloropurine was synthesized. Molecular docking of the synthesized analogs of 2-chloroadenosine by their affinity for A adenosine receptors (A ARs) was conducted. The investigation of A AR stimulating activity of synthesized nucleosides was carried out in a model of an isolated mouse atrium. We have shown that derivatives with tyrosine, valine, and serine residues exhibit the properties of A AR partial agonists. Animal experiments in the open field test have shown that these compounds have different profiles of psychoactive action. These nucleosides have an ophthalmic hypotensive effect and reduce intraocular pressure in a manner slightly inferior to that of timolol and brimonidine. The synthesized nucleosides can be the basis for further design and synthesis of new A AR agonists.
doi_str_mv 10.1016/j.bioorg.2022.105878
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_35660725</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>35660725</sourcerecordid><originalsourceid>FETCH-pubmed_primary_356607253</originalsourceid><addsrcrecordid>eNqFjs1OwzAQhC0k1JafN0BoXyDBdpukHFEF4l7u1SZ2m60Sb-R1QD3y5iQSnDnNaGb0aZR6MDo32pRP57wm5njKrbZ2iopttb1SK6OfdWaN1Ut1I3LW2phNVS7Ucl2Upa5ssVLf-0tIrRcS4CPYrGk7jjyMkYKHSDULOS_wRamFpqWIHWBPgQEbcrOdW0ywKwGDgwlFEfwndiMm4gAo8AIG0PkwoWamb_yQOAKeOJAkuVPXR-zE3__qrXp8e_3YvWfDWPfeHYZIPcbL4e_z-t_BD1BCVOQ</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Synthesis of 2-chloropurine ribosides with chiral amino acid amides at C6 and their evaluation as A 1 adenosine receptor agonists</title><source>Elsevier ScienceDirect Journals</source><creator>Berzina, Maria Ya ; Eletskaya, Barbara Z ; Kayushin, Alexei L ; Dorofeeva, Elena V ; Lutonina, Olga I ; Fateev, Ilya V ; Paramonov, Alexander S ; Kostromina, Maria A ; Zayats, Evgeniy A ; Abramchik, Yulia A ; Maltsev, Dmitriy V ; Naumenko, Ludmila V ; Taran, Alena S ; Yakovlev, Dmitry S ; Spasov, Alexander A ; Miroshnikov, Anatoly I ; Esipov, Roman S ; Konstantinova, Irina D</creator><creatorcontrib>Berzina, Maria Ya ; Eletskaya, Barbara Z ; Kayushin, Alexei L ; Dorofeeva, Elena V ; Lutonina, Olga I ; Fateev, Ilya V ; Paramonov, Alexander S ; Kostromina, Maria A ; Zayats, Evgeniy A ; Abramchik, Yulia A ; Maltsev, Dmitriy V ; Naumenko, Ludmila V ; Taran, Alena S ; Yakovlev, Dmitry S ; Spasov, Alexander A ; Miroshnikov, Anatoly I ; Esipov, Roman S ; Konstantinova, Irina D</creatorcontrib><description>A series of purine ribonucleosides bearing chiral amino acid amides at the C6 position of 2-chloropurine was synthesized. Molecular docking of the synthesized analogs of 2-chloroadenosine by their affinity for A adenosine receptors (A ARs) was conducted. The investigation of A AR stimulating activity of synthesized nucleosides was carried out in a model of an isolated mouse atrium. We have shown that derivatives with tyrosine, valine, and serine residues exhibit the properties of A AR partial agonists. Animal experiments in the open field test have shown that these compounds have different profiles of psychoactive action. These nucleosides have an ophthalmic hypotensive effect and reduce intraocular pressure in a manner slightly inferior to that of timolol and brimonidine. The synthesized nucleosides can be the basis for further design and synthesis of new A AR agonists.</description><identifier>EISSN: 1090-2120</identifier><identifier>DOI: 10.1016/j.bioorg.2022.105878</identifier><identifier>PMID: 35660725</identifier><language>eng</language><publisher>United States</publisher><ispartof>Bioorganic chemistry, 2022-05, Vol.126, p.105878</ispartof><rights>Copyright © 2022 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35660725$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berzina, Maria Ya</creatorcontrib><creatorcontrib>Eletskaya, Barbara Z</creatorcontrib><creatorcontrib>Kayushin, Alexei L</creatorcontrib><creatorcontrib>Dorofeeva, Elena V</creatorcontrib><creatorcontrib>Lutonina, Olga I</creatorcontrib><creatorcontrib>Fateev, Ilya V</creatorcontrib><creatorcontrib>Paramonov, Alexander S</creatorcontrib><creatorcontrib>Kostromina, Maria A</creatorcontrib><creatorcontrib>Zayats, Evgeniy A</creatorcontrib><creatorcontrib>Abramchik, Yulia A</creatorcontrib><creatorcontrib>Maltsev, Dmitriy V</creatorcontrib><creatorcontrib>Naumenko, Ludmila V</creatorcontrib><creatorcontrib>Taran, Alena S</creatorcontrib><creatorcontrib>Yakovlev, Dmitry S</creatorcontrib><creatorcontrib>Spasov, Alexander A</creatorcontrib><creatorcontrib>Miroshnikov, Anatoly I</creatorcontrib><creatorcontrib>Esipov, Roman S</creatorcontrib><creatorcontrib>Konstantinova, Irina D</creatorcontrib><title>Synthesis of 2-chloropurine ribosides with chiral amino acid amides at C6 and their evaluation as A 1 adenosine receptor agonists</title><title>Bioorganic chemistry</title><addtitle>Bioorg Chem</addtitle><description>A series of purine ribonucleosides bearing chiral amino acid amides at the C6 position of 2-chloropurine was synthesized. Molecular docking of the synthesized analogs of 2-chloroadenosine by their affinity for A adenosine receptors (A ARs) was conducted. The investigation of A AR stimulating activity of synthesized nucleosides was carried out in a model of an isolated mouse atrium. We have shown that derivatives with tyrosine, valine, and serine residues exhibit the properties of A AR partial agonists. Animal experiments in the open field test have shown that these compounds have different profiles of psychoactive action. These nucleosides have an ophthalmic hypotensive effect and reduce intraocular pressure in a manner slightly inferior to that of timolol and brimonidine. The synthesized nucleosides can be the basis for further design and synthesis of new A AR agonists.</description><issn>1090-2120</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFjs1OwzAQhC0k1JafN0BoXyDBdpukHFEF4l7u1SZ2m60Sb-R1QD3y5iQSnDnNaGb0aZR6MDo32pRP57wm5njKrbZ2iopttb1SK6OfdWaN1Ut1I3LW2phNVS7Ucl2Upa5ssVLf-0tIrRcS4CPYrGk7jjyMkYKHSDULOS_wRamFpqWIHWBPgQEbcrOdW0ywKwGDgwlFEfwndiMm4gAo8AIG0PkwoWamb_yQOAKeOJAkuVPXR-zE3__qrXp8e_3YvWfDWPfeHYZIPcbL4e_z-t_BD1BCVOQ</recordid><startdate>20220518</startdate><enddate>20220518</enddate><creator>Berzina, Maria Ya</creator><creator>Eletskaya, Barbara Z</creator><creator>Kayushin, Alexei L</creator><creator>Dorofeeva, Elena V</creator><creator>Lutonina, Olga I</creator><creator>Fateev, Ilya V</creator><creator>Paramonov, Alexander S</creator><creator>Kostromina, Maria A</creator><creator>Zayats, Evgeniy A</creator><creator>Abramchik, Yulia A</creator><creator>Maltsev, Dmitriy V</creator><creator>Naumenko, Ludmila V</creator><creator>Taran, Alena S</creator><creator>Yakovlev, Dmitry S</creator><creator>Spasov, Alexander A</creator><creator>Miroshnikov, Anatoly I</creator><creator>Esipov, Roman S</creator><creator>Konstantinova, Irina D</creator><scope>NPM</scope></search><sort><creationdate>20220518</creationdate><title>Synthesis of 2-chloropurine ribosides with chiral amino acid amides at C6 and their evaluation as A 1 adenosine receptor agonists</title><author>Berzina, Maria Ya ; Eletskaya, Barbara Z ; Kayushin, Alexei L ; Dorofeeva, Elena V ; Lutonina, Olga I ; Fateev, Ilya V ; Paramonov, Alexander S ; Kostromina, Maria A ; Zayats, Evgeniy A ; Abramchik, Yulia A ; Maltsev, Dmitriy V ; Naumenko, Ludmila V ; Taran, Alena S ; Yakovlev, Dmitry S ; Spasov, Alexander A ; Miroshnikov, Anatoly I ; Esipov, Roman S ; Konstantinova, Irina D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_356607253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berzina, Maria Ya</creatorcontrib><creatorcontrib>Eletskaya, Barbara Z</creatorcontrib><creatorcontrib>Kayushin, Alexei L</creatorcontrib><creatorcontrib>Dorofeeva, Elena V</creatorcontrib><creatorcontrib>Lutonina, Olga I</creatorcontrib><creatorcontrib>Fateev, Ilya V</creatorcontrib><creatorcontrib>Paramonov, Alexander S</creatorcontrib><creatorcontrib>Kostromina, Maria A</creatorcontrib><creatorcontrib>Zayats, Evgeniy A</creatorcontrib><creatorcontrib>Abramchik, Yulia A</creatorcontrib><creatorcontrib>Maltsev, Dmitriy V</creatorcontrib><creatorcontrib>Naumenko, Ludmila V</creatorcontrib><creatorcontrib>Taran, Alena S</creatorcontrib><creatorcontrib>Yakovlev, Dmitry S</creatorcontrib><creatorcontrib>Spasov, Alexander A</creatorcontrib><creatorcontrib>Miroshnikov, Anatoly I</creatorcontrib><creatorcontrib>Esipov, Roman S</creatorcontrib><creatorcontrib>Konstantinova, Irina D</creatorcontrib><collection>PubMed</collection><jtitle>Bioorganic chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berzina, Maria Ya</au><au>Eletskaya, Barbara Z</au><au>Kayushin, Alexei L</au><au>Dorofeeva, Elena V</au><au>Lutonina, Olga I</au><au>Fateev, Ilya V</au><au>Paramonov, Alexander S</au><au>Kostromina, Maria A</au><au>Zayats, Evgeniy A</au><au>Abramchik, Yulia A</au><au>Maltsev, Dmitriy V</au><au>Naumenko, Ludmila V</au><au>Taran, Alena S</au><au>Yakovlev, Dmitry S</au><au>Spasov, Alexander A</au><au>Miroshnikov, Anatoly I</au><au>Esipov, Roman S</au><au>Konstantinova, Irina D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of 2-chloropurine ribosides with chiral amino acid amides at C6 and their evaluation as A 1 adenosine receptor agonists</atitle><jtitle>Bioorganic chemistry</jtitle><addtitle>Bioorg Chem</addtitle><date>2022-05-18</date><risdate>2022</risdate><volume>126</volume><spage>105878</spage><pages>105878-</pages><eissn>1090-2120</eissn><abstract>A series of purine ribonucleosides bearing chiral amino acid amides at the C6 position of 2-chloropurine was synthesized. Molecular docking of the synthesized analogs of 2-chloroadenosine by their affinity for A adenosine receptors (A ARs) was conducted. The investigation of A AR stimulating activity of synthesized nucleosides was carried out in a model of an isolated mouse atrium. We have shown that derivatives with tyrosine, valine, and serine residues exhibit the properties of A AR partial agonists. Animal experiments in the open field test have shown that these compounds have different profiles of psychoactive action. These nucleosides have an ophthalmic hypotensive effect and reduce intraocular pressure in a manner slightly inferior to that of timolol and brimonidine. The synthesized nucleosides can be the basis for further design and synthesis of new A AR agonists.</abstract><cop>United States</cop><pmid>35660725</pmid><doi>10.1016/j.bioorg.2022.105878</doi></addata></record>
fulltext fulltext
identifier EISSN: 1090-2120
ispartof Bioorganic chemistry, 2022-05, Vol.126, p.105878
issn 1090-2120
language eng
recordid cdi_pubmed_primary_35660725
source Elsevier ScienceDirect Journals
title Synthesis of 2-chloropurine ribosides with chiral amino acid amides at C6 and their evaluation as A 1 adenosine receptor agonists
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T23%3A04%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%202-chloropurine%20ribosides%20with%20chiral%20amino%20acid%20amides%20at%20C6%20and%20their%20evaluation%20as%20A%201%20adenosine%20receptor%20agonists&rft.jtitle=Bioorganic%20chemistry&rft.au=Berzina,%20Maria%20Ya&rft.date=2022-05-18&rft.volume=126&rft.spage=105878&rft.pages=105878-&rft.eissn=1090-2120&rft_id=info:doi/10.1016/j.bioorg.2022.105878&rft_dat=%3Cpubmed%3E35660725%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/35660725&rfr_iscdi=true